Travere Therapeutics TVTX
NASDAQ TVTX
$59.99 -1.58 (-2.57%)
At close: Sep 29, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Total Current Liabilities (2012 - 2026)

Updated

Travere Therapeutics (TVTX) posted Total Current Liabilities of $152.03 million for Q2 2026, down 19.8% from $189.54 million a year earlier but up 21.2% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Total Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Travere Therapeutics' Total Current Liabilities came in at $159.9 million, down 20.3% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
  • In prior years, Travere Therapeutics' Total Current Liabilities was $200.75 million in FY2024 (+12.8%), $177.91 million in FY2023 (+25.1%), $142.16 million in FY2022 (+14.6%) and $124.09 million in FY2021 (+33.9%).
  • Quarterly Total Current Liabilities has run from a low of $113.16 million in Q3 2021 to a high of $200.75 million in Q4 2024 over five years.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last four quarters, with growth averaging 1.3% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2025, with growth of 56.3%; the weakest was Q1 2026, with a decline of 31.3%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $125.44 million (Q1 2026), $159.9 million (Q4 2025) and $135.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Travere Therapeutics 5.80 Bn 5.40 Bn 167.41 Mn 152.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 152.03 Mn
Mar 31, 2026 125.44 Mn
Dec 31, 2025 159.90 Mn
Sep 30, 2025 135.07 Mn
Jun 30, 2025 189.54 Mn
Mar 31, 2025 182.46 Mn
Dec 31, 2024 200.75 Mn
Sep 30, 2024 190.04 Mn
Jun 30, 2024 121.27 Mn
Mar 31, 2024 173.23 Mn
Dec 31, 2023 177.91 Mn
Sep 30, 2023 139.43 Mn
Jun 30, 2023 135.71 Mn
Mar 31, 2023 130.65 Mn
Dec 31, 2022 142.16 Mn
Sep 30, 2022 131.03 Mn
Jun 30, 2022 124.49 Mn
Mar 31, 2022 119.47 Mn
Dec 31, 2021 124.09 Mn
Sep 30, 2021 113.16 Mn
API Access

Travere Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TVTX&period=max&api_key=YOUR_API_KEY